Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-02-09
4:19 pm
Sale		13GCentury Therapeutics, Inc.
IPSC		Versant Venture Capital VI L.P.11,452,014
19.4%		-914,800decrease
(-7.40%)		View
2023-02-09
09:59 am
Sale		13GCentury Therapeutics, Inc.
IPSC		FMR LLC7,096,411
12.033%		-1,099,792decrease
(-13.42%)		View
2022-10-11
2:09 pm
Sale		13DCentury Therapeutics, Inc.
IPSC		Casdin Capital LLC3,222,940
5.5%		-23,184decrease
(-0.71%)		View
2022-02-11
4:35 pm
Purchase		13GCentury Therapeutics, Inc.
IPSC		BAYER AKTIENGESELLSCHAFT12,675,838
23.2%		12,675,838increase
(New Position)		View
2022-02-11
4:30 pm
Purchase		13GCentury Therapeutics, Inc.
IPSC		FUJIFILM Cellular Dynamics Inc.6,955,207
12.7%		6,955,207increase
(New Position)		View
2022-02-10
8:39 pm
Purchase		13GCentury Therapeutics, Inc.
IPSC		Versant Venture Capital VI L.P.12,366,814
22.6%		12,366,814increase
(New Position)		View
2022-02-09
09:11 am
Purchase		13GCentury Therapeutics, Inc.
IPSC		FMR LLC8,196,203
14.999%		943,642increase
(+13.01%)		View
2021-08-10
10:33 am
Purchase		13GCentury Therapeutics, Inc.
IPSC		FMR LLC7,252,561
12.857%		7,252,561increase
(New Position)		View
2021-07-29
2:11 pm
Purchase		13DCentury Therapeutics, Inc.
IPSC		Casdin Capital LLC3,246,124
5.9%		3,246,124increase
(New Position)		View